Evidence map›Paper›PMID 32319790›Full record

ArticleEnvironmental health perspectives2020

Maternal Plasma Perfluoroalkyl Substances and Miscarriage: A Nested Case-Control Study in the Danish National Birth Cohort.

Zeyan Liew, Jiajun Luo, Ellen A Nohr, Bodil Hammer Bech, Rossana Bossi, Onyebuchi A Arah, Jørn Olsen

Open access · diamondAbstract read
In one paragraph

Article in Environmental health perspectives, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 3 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 3 syntheses or guidelines pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Zeyan LiewDepartment of Environmental Health Sciences, Yale School of Public Health, New Haven, Connecticut, USA.
Jiajun LuoDepartment of Environmental Health Sciences, Yale School of Public Health, New Haven, Connecticut, USA.
Ellen A NohrInstitute of Clinical Research, University of Southern Denmark, Odense, Denmark.
Bodil Hammer BechDepartment of Public Health, Research Unit for Epidemiology, University of Aarhus, Aarhus, Denmark.
Rossana BossiDepartment of Environmental Science, University of Aarhus, Roskilde, Denmark.
Onyebuchi A ArahDepartment of Public Health, Research Unit for Epidemiology, University of Aarhus, Aarhus, Denmark.
Jørn OlsenDepartment of Clinical Epidemiology, Aarhus University Hospital, Skejby, Denmark.
Aarhus University · DKProvidence Center · USAarhus University Hospital · DKUniversity of California, Los Angeles · USUniversity of Southern Denmark · DK

Funding

Scientific and Technical CoreP2CHD041022 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Martha Jane Bailey · 2016 to 2026
$6.9M
Neurodevelopmental Effects of Perfluorinated ChemicalsR00ES026729 · NIEHS · YALE UNIVERSITY · PI LIEW, ZEYAN · 2018 to 2020
$742k
NICHD NIH HHS P2C HD041022NIEHS NIH HHS R00 ES026729
6 · The paper itself

Abstract

backgroundPer- and polyfluoroalkyl substances (PFAS) are widespread persistent organic pollutants and endocrine disruptors. High doses of perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) exposure can cause pregnancy loss and infant deaths in animals, but the associations between PFAS exposures and risk of miscarriage in humans are not well studied.

methodsUsing a case-control study nested within the Danish National Birth Cohort (DNBC, 1996-2002), we compared 220 pregnancies ending in miscarriage during weeks 12-22 of gestation, with 218 pregnancies resulting in live births. Levels of seven types of PFAS [PFOS, PFOA, perfluorohexane sulfonate (PFHxS), perfluoroheptane sulfonate (PFHpS), perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), and perfluorooctanesulfonic acid (PFOSA)] were measured in maternal plasma collected in early gestation (mean gestational week 8). We estimated the odds ratios (ORs) and 95% confidence intervals (CIs) for miscarriage and each PFAS as a continuous variable or in quartiles, controlling for maternal age, parity, socio-occupational status, smoking and alcohol intake, gestational week of blood sampling, and maternal history of miscarriage. Stratification by parity and PFAS mixture analyses using weighted quantile sum (WQS) regression were also conducted.

resultsWe observed a monotonic increase in odds for miscarriage associated with increasing PFOA and PFHpS levels. The ORs comparing the highest PFOA or PFHpS quartile to the lowest were 2.2 (95% CI: 1.2, 3.9) and 1.8 (95% CI: 1.0, 3.2). The ORs were also elevated for the second or third quartile of PFHxS or PFOS, but no consistent exposure-outcome pattern emerged. An interquartile range (IQR) increment in the WQS index of seven PFAS was associated with 64% higher odds for miscarriage (95% CI: 1.15, 2.34). The associations were stronger in parous women, while findings were inconsistent among nulliparous women.

conclusionMaternal exposures to higher levels of PFOA, PFHpS, and PFAS mixtures were associated with the risk of miscarriage and particularly among parous women. Larger replication studies among nulliparous women are needed to allay concerns about confounding by reproductive history. https://doi.org/10.1289/EHP6202.

Indexed as

Abortion, SpontaneousAdultCase-Control StudiesDenmarkEndocrine DisruptorsEnvironmental PollutantsFemaleFluorocarbonsHumansMaternal ExposureYoung AdultEndocrine DisruptorsEnvironmental PollutantsFluorocarbons

Identifiers

PMID32319790
PMCPMC7228130
OpenAlexW3016912298

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.